
News|Articles|May 8, 2024
Long-Acting Injectables: Part 1 of a Conversation With Peter J. Weiden, MD
Author(s)Peter J. Weiden, MD, John J. Miller, MD
Peter J. Weiden, MD, sat down with Psychiatric Times’ Editor-in-Chief at the 2024 Annual Meeting. Here’s Part 1 of their conversation.
Advertisement
CONFERENCE REPORTER
Psychiatric Times Editor-in-Chief, John J. Miller, MD, sat down with his colleague, Peter J. Weiden, MD, of the State University of New York at Stony Brook at the
Dr Weiden is a professor at the State University of New York at Stony Brook.
See more coverage from the 2024 APA Annual Meeting in Psychiatric Times at
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Issues CRL for CTx-1301 for Treatment of ADHD
2
Insights Into Mechanism-Based Biomarkers for Psychosis Prediction from Kim Do, PhD
3
New Name, New Path for Psychiatry: The Future of the DSM
4
Nonpharmacological Augmentation of Ketamine, Neuroplasticity, and Behavioral Therapy
5







